TELADOC HEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.73 USD | -1.32% |
|
+6.53% | -40.93% |
| Apr. 29 | Truist Securities Cuts Teladoc's Price Target to $15 From $17, Maintains Hold Rating | MT |
| Apr. 26 | UBS Adjusts Teladoc Price Target to $16 From $20, Maintains Neutral Rating | MT |
Presentation Operator MessageOperator (Operator)Welcome to the Teladoc Health's 2020 Annual Me...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Teladoc Health, Inc. provides virtual healthcare services. The Company operates through two segments: Teladoc Health Integrated Care (Integrated Care) and BetterHelp. The Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed primarily on a business-to-business (B2B) basis. The BetterHelp segment primarily consists of its direct-to-consumer (D2C) mental health platform. The online counseling and therapy services are provided via its network of over 40,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs.
Calendar
2024-05-23
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
27
Last Close Price
12.73
USD
Average target price
17.19
USD
Spread / Average Target
+35.04%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -40.93% | 2.16B | |
| +63.71% | 3.13B | |
| +115.18% | 703M | |
| +8.27% | 467M | |
| -67.19% | 145M | |
| -32.23% | 85.06M |
- Stock Market
- Equities
- TDOC Stock
- News Teladoc Health, Inc.
- Transcript : Teladoc Health, Inc. - Shareholder/Analyst Call
